India Stock Market Daily Regulatory Digest — October 19, 2026

18-10-2026

YES BANK Limited disclosed that it has received a communication dated October 16, 2026 from Axis Trustee Services Limited regarding payment of the annual coupon on its 9.00% Perpetual Subordinated Unsecured Non-Convertible Basel III Compliant Additional Tier I Bonds (Series II, ISIN INE528G08394). The Bank responded that coupon payment is subject to a Supreme Court of India judgement dated October 15, 2026 and the conditionalities in the Information Memorandum, and that it is evaluating legal options. Because the judgement materially affects coupon payment on AT1 bonds, this is a significant and uncertain development for bondholders.

• · Coupon payment is conditional on the Supreme Court of India judgement dated October 15, 2026 and Information Memorandum conditionalities
• · The Bank is evaluating legal options and suitable actions following the judgement
• · This follows earlier disclosures on the Supreme Court judgement dated October 15 and 16, 2026 and results announced October 17, 2026

18-10-2026

Creative Castings Limited submitted a routine Regulation 74(5) confirmation certificate from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited, for the quarter ended September 30, 2026. The certificate confirms that securities received for dematerialisation during the quarter were confirmed or rejected to the depositories and that the relevant securities were listed on the stock exchanges where the earlier issued securities are listed. The filing contains no financial results, specific monetary amounts, or performance metrics.

• · Scrip Code on BSE is 539527
• · Certificate is issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
• · Confirmation certificate is dated October 3, 2026, and the cover letter is dated October 18, 2026

18-10-2026

Andhra Pradesh Tanneries Ltd (BSE Scrip Code 509367) filed an intimation under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, enclosing a confirmation certificate from its Registrar and Share Transfer Agent, Satellite Corporate Services Pvt. Ltd., for the quarter ended September 30, 2026. The certificate states that no physical share certificates were received for dematerialization during the quarter, so no shares were listed or cancelled in that period. This is a routine compliance filing with no financial performance data.

• · No physical share certificates were received for dematerialization during the quarter ended September 30, 2026
• · Registered office is at Leather Complex Area, Nellimarla, Vizianagaram District, Andhra Pradesh; CIN L19110AP1974PLC001711

18-10-2026

Rossari Biotech Limited submitted to BSE and NSE a copy of the newspaper publication (Financial Express English and Loksatta Marathi, both dated October 18, 2026) of the extract of its Consolidated Unaudited Financial Results for the quarter and half year ended September 30, 2026, under Regulations 30 and 47 of SEBI LODR. The filing itself contains no financial figures; the results are referenced only by publication. The remainder of the document consists of unrelated newspaper advertisements from other companies (KDDL, Quint Digital, Fischer Medical Ventures, Lagnam Spintex, Utkal Energy, among others).

• · Filing made under Regulation 30 and 47 of SEBI (LODR) Regulations, 2015
• · Financial results covered are for the quarter and half year ended September 30, 2026
• · Rossari's stock codes: 543213 (BSE) and ROSSARI (NSE)

18-10-2026

Available Finance Ltd. submitted to BSE Limited a Regulation 74(5) certificate issued by its Registrar and Share Transfer Agent, Ankit Consultancy Pvt. Ltd., for the quarter ended 30 September 2026. The certificate confirms that securities received for dematerialization during the quarter were confirmed to the depositories, listed on the relevant stock exchanges, and that the physical certificates were mutilated and cancelled, with depository names substituted in the register of members within 15 days. This is a routine compliance filing with no financial performance data.

• · BSE scrip code is 531310
• · Certificate covers the quarter ended 30 September 2026 and is dated 18 October 2026
• · Registrar and Share Transfer Agent is registered with SEBI (registration no. INR 000000767)

19-10-2026

19-10-2026

19-10-2026

Hero MotoCorp Limited disclosed under Regulation 30 of the SEBI Listing Regulations that NSE Sustainability Ratings & Analytics, a SEBI-registered Category I ESG ratings provider, has assigned the Company an ESG Score of 72, notified on October 16, 2026. The Company states it did not commission this assessment, which was based on publicly available data for FY 2025-26. The filing is an informational intimation with no financial results, deal terms, or regulatory action disclosed.

• · ESG rating was assigned without the Company commissioning or engaging NSE Sustainability Ratings & Analytics
• · Assessment is based solely on publicly available data for FY 2025-26
• · Notification received on October 16, 2026 and disclosed on October 19, 2026

19-10-2026

19-10-2026

Max Financial Services Limited (MFSL), holding company of Axis Max Life Insurance Limited, has scheduled an earnings conference call on Wednesday, October 28, 2026 at 10:00 A.M. IST to discuss its Q2 and H1 FY27 financial results, with senior management from MFSL and AMLI participating. This is a routine scheduling intimation under Regulation 30 and does not itself disclose any financial results or performance metrics.

• · MFSL holds an 80.01% majority stake in AMLI, described as India's largest non-bank, private life insurance company
• · The call will be hosted with a pre-registration 'Diamond Pass' and dial-in numbers in India, USA, UK, Singapore and Hong Kong
• · The disclosure will also be hosted on the Company's website www.maxfinancialservices.com

19-10-2026

CARE Ratings Limited executed Share Purchase Agreements and a Shareholders' Agreement on October 19, 2026 with State Bank of India (SBI) and NSE IFSC Limited (NSEIX) to sell 9.90% equity stake each in its wholly owned subsidiary CareEdge Global IFSC Limited (CGIL). Upon completion of closing actions, expected within two months, CGIL will cease to be a wholly owned subsidiary, with CARE Ratings retaining an 80.20% equity stake. The disclosure follows earlier intimations dated November 12, 2025 and May 13, 2026 on the same transaction.

• · Closing actions are expected to be completed within two months of October 19, 2026
• · Transaction disclosed under Regulation 30 of SEBI (LODR) Regulations, 2015
• · Filing also made available on the company website www.careedge.in

19-10-2026

19-10-2026

Qualitek Labs Limited disclosed under Regulation 30 that its wholly owned subsidiary, Interstellar Testing Centre Private Limited, received a work order from Bio-Resources Development Centre (BRDC), a Government of Meghalaya R&D institution, to support the setup, operation and accreditation of a Quality Control and Analytical Laboratory at BRDC Experimental Farm, Laitmynsaw, Upper Shillong. The company describes the order as being in the normal course of business, and the contract value and execution timeline are withheld on grounds of commercial confidentiality.

• · Order awarded by a Government of Meghalaya R&D institution under the Science & Technology, Planning Department
• · Company states the order is domestic and in the normal course of business
• · No promoter, promoter group or group company interest in the awarding entity; not a related party transaction
• · Contract value and execution period not disclosed on grounds of commercial confidentiality

19-10-2026

19-10-2026

NATCO Pharma announced the U.S. launch of Carboplatin Injection, a generic of Paraplatin®, through its U.S. subsidiary NATCO Pharma USA LLC, in manufacturing collaboration with Teyro Labs Pvt Ltd of Chennai. The launch is positioned as addressing a critical U.S. shortage of the product, and the molecule had estimated U.S. sales of USD 27.8 million for the 12 months ending June 2026 per industry sales data. The filing is a product launch announcement and does not disclose any financial results or guidance for the company.

• · Carboplatin Injection is indicated for advanced ovarian carcinoma, including first-line combination therapy and palliative treatment of recurrent disease after prior chemotherapy
• · Launch is made in manufacturing collaboration with Teyro Labs Pvt Ltd, based in Chennai
• · Company is an oncology-focused player that targets limited-competition molecules in the U.S.
• · Manufacturing facilities are approved by US FDA, Brazil ANVISA, Health Canada, WHO and others

19-10-2026

Dharan Infra-EPC Limited disclosed that the Hon'ble NCLT Mumbai Bench, by its order dated October 16, 2026, dismissed the application seeking withdrawal of the Corporate Insolvency Resolution Process (CIRP), which had been filed on the basis of a settlement with creditor Tata Capital. The CIRP will therefore continue under the Insolvency and Bankruptcy Code, 2016 and its applicable timelines. The intimation was filed by the Interim Resolution Professional, Palak Swapnil Desai, under Regulation 30 of the SEBI (LODR) Regulations, 2015.

• · The withdrawal application was based on a settlement with creditor Tata Capital, which the NCLT rejected
• · The NCLT order is dated October 16, 2026; the disclosure to exchanges was made on October 19, 2026
• · The IRP's registration is IBBI/IPA-001/IP-P-01517/2019-2020/12515, with AFA valid until 30.06.2027

19-10-2026

Mirza International Limited has incorporated a new 100% wholly owned subsidiary, Mirza Footwear Limited, on October 19, 2026, to carry on manufacturing, retail, wholesale marketing and e-commerce of footwear. The subsidiary has an authorised share capital of Rs. 15,00,000 and has not yet commenced business, so no turnover or historical financials are available. The parent will fund the entity through a 100% initial subscription to its share capital in cash.

• · Target entity CIN: U47710UP2026PLC260158; country of incorporation: India
• · Transaction is classified as a related party transaction since the target is a wholly owned subsidiary of the promoter company
• · No governmental or regulatory approvals required; no indicative completion period applicable
• · Cost of acquisition and acquisition price are not applicable as the entity is newly incorporated and funded through share subscription
• · Filing made under Regulation 30 of SEBI LODR Regulations, 2015, with disclosure details per Schedule III and SEBI Master Circular

19-10-2026

Knack Packaging Ltd has scheduled a Board of Directors meeting for 27 October 2026 to consider and approve the standalone and consolidated unaudited financial results for the second quarter and half year ended 30 September 2026, as required under Regulation 33 of the SEBI LODR Regulations. The company has also closed the trading window for insiders, designated persons, connected persons and their immediate relatives from 1 October 2026 until 48 hours after the results are made public.

• · Board meeting date: Tuesday, 27 October 2026, under Regulation 29(1)(a) of SEBI LODR
• · Trading window closure effective from 1 October 2026 until 48 hours after financial results are made public
• · Trading window closure was intimated to exchanges via letter dated 25 September 2026
• · Scrip code 544814, symbol KNACK

19-10-2026

Quanto Agroworld Limited has informed BSE that its Board will meet on Saturday, 24 October 2026 to consider and approve unaudited financial results for the half year ended 30 September 2026. The company also confirmed that the trading window for all insiders under its Code of Conduct will remain closed until 26 October 2026.

• · Board meeting scheduled for Saturday, 24 October 2026, filed under SEBI LODR Regulation 29(1) and (2)
• · Trading window closure for insiders extended from the earlier notice dated 29 September 2026, now running until 26 October 2026
• · Security code 544932, security ID QAL on BSE

19-10-2026

Carysil Limited has intimated under Regulation 29 of SEBI LODR that its Board of Directors will meet on Wednesday, November 04, 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The company also confirmed that its trading window for designated persons has been closed since October 01, 2026 and will reopen on November 07, 2026, 48 hours after results declaration.

• · Board meeting scheduled for November 04, 2026 to approve unaudited standalone and consolidated results for Q2 and H1 FY ended September 30, 2026
• · Trading window closed from October 01, 2026 and reopens November 07, 2026
• · Trading window closure is referenced to an earlier intimation dated September 25, 2026

19-10-2026

Icon Facilitators Limited disclosed under Regulation 30 of the SEBI Listing Regulations that it received a manpower services contract from Knight Frank (India) Private Limited for work at Fujitsu Consulting India Private Limited in Noida, with a total contract value of Rs. 63,30,436 and an execution period of 210 days (described as 7 months in the disclosure annexure). The filing states no promoter interest in the transaction and that it does not qualify as a related party transaction.

• · Work location is A-207, Sec-23, Noida, UP-201301
• · Contract is domestic and no promoter or promoter group interest is involved
• · Transaction is not classified as a related party transaction
• · Filing references SEBI Master Circular No. SEBI/HO/CFD/PoD2/P/0155 dated November 11, 2024 and SEBI/HO/CFD/CFD-PoD-2/P/CIR/P/2024/185 dated December 31, 2024

19-10-2026

Sumitomo Chemical India Limited has intimated under Regulation 30(6) of the SEBI LODR Regulations that an earnings call to discuss financial performance for the quarter and half-year ended 30 September 2026 (Q2 & H1 FY27) will be held on Tuesday, 27 October 2026 at 02:30 PM IST. The call will be hosted by senior management including the Managing Director, EVP, CFO and Company Secretary. The filing contains no financial figures, so no performance comparison is possible from this document.

• · Earnings call date and time: Tuesday, 27 October 2026 at 02:30 PM IST
• · Scrip code 542920, symbol SUMICHEM
• · Earnings call invite also hosted on the company website
• · RSVP contacts are Jigar Kavaiya / Parin Narichania of Strategic Growth Advisors Pvt. Ltd.

19-10-2026

Sejal Glass Limited filed an investor presentation under Regulation 30 for the quarter and half year ended September 30, 2026 (Q2 FY27). Consolidated Q2 FY27 revenue from operations was ₹138.09 Cr, up 32.8% YoY, with EBITDA margin of 18.35% (up 132 bps) and net profit margin of 10.31% (up 258 bps). The company's network has a total annual processing capacity of 61.94 Lakh Sq. Mt. at 54% utilisation, and its Silvassa plant's tempering line rose to 82% utilisation in Q2 FY27.

• · Company acquired Glasstech Industries in 2025; Taloja and Erode facilities were transferred via business transfer from Glasstech in April 2025
• · India tempering capacity rose from 7.80 to 24.01 Lakh Sq. Mt. and India capacity from 10.68 to 34.24 Lakh Sq. Mt. post-Glasstech
• · Railway-grade glass is an approved vendor product; company is bidding for Vande Bharat orders
• · Taloja and Erode plants are at 33% and 13% utilisation in FY26, indicating underutilised capacity
• · Railway-grade insulated and laminated glass rose to 68% of India sales in FY26 from 63% in FY25; insulated glass sales grew 2.8x
• · UAE hospitality orders within AED 27.6 mn win; first European order received in Q4 FY26; Africa exports started FY26
• · BR2 ballistic testing completed in India for high-security applications

19-10-2026

Wanbury Limited disclosed via a Regulation 30 filing that its Patalganga (Maharashtra) API facility received the National Safety Council's Certificate of Excellence for safety performance for the third consecutive year, and its Tanuku (Andhra Pradesh) API facility was named 'Best Employer' by the State Government. The filing is a recognition announcement with no financial figures, guidance, or performance metrics disclosed.

• · Facilities are USFDA and EUGMP approved (Tanuku and Patalganga)
• · APIs exported to over 50 countries
• · Company established in 1988 with script codes 524212 (BSE) and WANBURY (NSE)

19-10-2026

Galaxy Bearings Ltd. has intimated to BSE under Regulation 29 of the SEBI LODR Regulations that its Board will meet on October 26, 2026 to consider and take on record the unaudited financial results for the quarter and half-year ended September 30, 2026, along with any other business with the Chairperson's permission. The company reiterates that its trading window for insiders has been closed since October 1, 2026 and will reopen 48 hours after the results are declared. No financial figures are disclosed in this filing.

• · Board meeting scheduled for Monday, October 26, 2026 to approve unaudited results for quarter and half-year ended September 30, 2026
• · Insider trading window closed from Thursday, October 1, 2026, until 48 hours after results declaration
• · Trading window closure was previously intimated to BSE via letter dated September 25, 2026
• · Scrip Code 526073 (BSE), Scrip ID GALXBRG

19-10-2026

Kwality Pharmaceuticals Limited announced the acquisition of 4 acres of land adjacent to its existing manufacturing facility in Amritsar, Punjab, to support its next phase of growth. The company plans a fully automated facility with 4 injectable lines and 6+ lines for tablets, capsules, ophthalmic and other oral solid dosage formulations, designed with EU GMP (including Annex 1) considerations, targeting completion by Q4 FY2028 and full operations by Q2 FY2029. The filing does not disclose the acquisition consideration or any financial metrics.

• · Facility to be fully automated and designed with due consideration to EU GMP requirements, including Annex 1, where relevant
• · Expansion intended to meet demand for existing and upcoming products and create capacity for bioequivalence-led opportunities
• · Acquisition consideration and funding source not disclosed in the filing

19-10-2026

Viji Finance Limited has issued a Postal Ballot Notice seeking shareholder approval, via remote e-voting, to appoint M/s. DDS & Associates (Firm Registration No. 120362W) as Statutory Auditors to fill the casual vacancy caused by the resignation of M/s. Dharmendra K. Agarwal & Co. (Firm Registration No. 025525C). The appointment would run until the next AGM and cover the audit of the financial year ending 31 March 2027. E-voting runs from 26 October 2026 to 24 November 2026, with results expected by 26 November 2026.

• · Record date (cut-off) for voting eligibility is Friday, 16 October 2026
• · E-voting window: 9:00 AM IST, 26 October 2026 to 5:00 PM IST, 24 November 2026
• · Scrutinizer's result to be announced on or before 26 November 2026
• · Remuneration for the new auditor is to be determined per applicable law on Audit Committee recommendation and approved by the Managing Director
• · Board appointed L.N. Joshi as Scrutinizer at its meeting held 14 October 2026

19-10-2026

Centenial Surgical Suture Ltd. (BSE scrip 531308) wrote to the BSE Investigation/Surveillance Department on October 19, 2026, flagging an abnormal price fall not supported by any corporate announcement or material change in business, and alleging manipulative/unusual trades in its scrip. The company reported that on October 19, 2026 only 1 equity share traded at Rs.71.25 in the morning session, and it requested urgent surveillance action for possible misuse or unethical trading. The annexure lists weekly demat/remat and buy/sell activity by resident individuals from August 21 to October 16, 2026, with some holders showing large sell-downs (e.g., Jayendra Shrikant Kulkarni's holding fell from 24,268 to 17,192 over the period), while numerous small-to-large purchases were recorded across many accounts.

• · Company alleges the price fall is not supported by any corporate announcement or material change in business activities
• · Company requests urgent attention for possible misuse, unethical, or unusual trades and asserts the activity appears premeditated
• · The letter states the activity has been happening frequently, with prior letters referenced
• · Annexure covers weekly shareholding movements from August 21, 2026 to October 16, 2026, showing a mix of sell-downs and fresh buying across many resident individual accounts
• · Large single-week sell-downs include Jayendra Shrikant Kulkarni (6,330 shares sold Oct 09-16, 2026) and Harishchandra Sankalchand Mehta (889 to 850 shares)

19-10-2026

Sayaji Industries Limited executed a conveyance deed on 19 October 2026 to sell idle land measuring 63,787 square meters at Survey No. 1300 (old Survey No. 174), Final Plot No. 34/2, Village Kathwada, Taluka Dascroi, District Ahmedabad, Gujarat, for a consideration of Rs. 73,00,00,000 (Rupees Seventy-Three Crore Only). The buyer is a third party unrelated to the promoter or promoter group, and the transaction is not a related party transaction. The filing is a routine Regulation 30 disclosure referencing an earlier postal ballot approval dated 11 December 2023.

• · Land is located at Survey No. 1300 (old Survey No. 174), Final Plot No. 34/2, Village Kathwada, Taluka Dascroi, District Ahmedabad, Gujarat
• · Sale was executed under a conveyance deed with completion on the same date as the agreement
• · Transaction falls outside related party transaction rules and the buyer is not a promoter or promoter group entity
• · Disclosure made under Regulation 30 of SEBI LODR, referencing SEBI Master Circular dated 30 January 2026
• · Filing references a prior postal ballot intimation dated 11 December 2023 approving the asset sale

19-10-2026

Punj Lloyd Ltd has issued notice of its 38th Annual General Meeting, to be held on September 30, 2026 at the Registered Office in New Delhi, covering adoption of FY2026 standalone and consolidated financial statements, appointment of Statutory Auditors (M/s. Shah Dhandharia & Co. LLP) for five years, ratification of Cost Auditor remuneration of up to Rs 60,000 (M/s. KVM & Co.), and regularization of several Additional Directors. The filing contains no insolvency proceedings, despite being preliminarily tagged as Insolvency; no quantitative period-over-period financial results are disclosed.

• · Statutory auditor appointment is for an initial five-year term through the 43rd AGM in 2031, with a term of up to two five-year terms permitted under Section 139
• · Independent Director appointments for Sushama Oza and Toral Rajput are proposed as special resolutions for three-year terms
• · Rahul Singh Tomar was appointed as Additional Director effective July 31, 2026, the most recent board change
• · The AGM is noted as being held at shorter notice under Section 101 of the Companies Act, 2013

19-10-2026

CL Educate Limited's Board approved, on October 19, 2026, a Scheme of Amalgamation under Sections 230 to 232 of the Companies Act, 2013 under which its wholly owned subsidiary DEXIT Global Limited will be merged into the company. The scheme is subject to approval from the National Company Law Tribunal and other regulatory authorities. No shares will be issued and no cash consideration is involved, so the shareholding pattern of CL Educate will not change.

• · DEXIT Global Limited is a wholly owned subsidiary, so the transaction falls under the exemption for related party transactions in General Circular No. 30/2014 and Regulation 23(5)(b) of the Listing Regulations, and no arm's length assessment is required.
• · No valuation is required because no shares will be issued by CL Educate.
• · The amalgamation is intended to simplify the organizational structure, achieve economies of scale, and eliminate duplicated administrative costs and compliance overheads.
• · DEXIT operates in IT-enabled and digital services for the BFSI segment, which is a different business area from CL Educate's education and test preparation activities.

19-10-2026

Tata Elxsi reported operating revenue of INR 1055.7 crore for Q2 FY27, growing 2.3% in constant currency, with EBITDA of INR 231.4 crore (up 7.1% QoQ and 19.7% YoY) and an EBITDA margin of 21.9%, a 70 basis point sequential improvement. Growth was uneven: transportation grew 2% QoQ in constant currency, media and communication grew 3.4%, and healthcare and life sciences grew 3.5%, while Europe remained soft due to automotive weakness. Management expects H2 to be better than H1, but flagged Q3 furloughs and continued European deal delays as risks.

• · Margin expansion of 60-70 bps was driven by cross-currency benefits, with 10-20 bps from operational leverage and one-time costs going away, offsetting the annual wage revision.
• · Europe remained soft, with large automotive deals still awaiting decisions from big OEMs, and management noted no ramp-downs on signed Europe deals but slow ramp-up or status quo.
• · Management stated a Q3 furlough risk is pending customer-specific direction, and Q3 is typically a short quarter with fewer working days.
• · JLR was described as going through its own challenges including layoffs, which management is monitoring closely.
• · Management does not provide formal guidance as a policy; the only forward view is that H2 FY27 revenue is expected to exceed H1 on a YoY basis.

19-10-2026

GEM Enviro Management Limited (BSE: 544199) has acquired a 75% stake in Novuscom Neo Private Limited through the allotment on October 19, 2026 of 30,000 equity shares and 2,70,000 0.001% compulsorily convertible preference shares (CCPS), each of face value Rs. 10, on a preferential basis for a total cost of Rs. 30,00,000 paid in cash. Novuscom, incorporated November 3, 2025, has not yet commenced business operations and will become a subsidiary of the company, operating in sustainability-focused analytics and brand assessment, which the company describes as aligned with its environmental sustainability core business. No governmental or regulatory approvals are required.

• · Novuscom has not commenced business operations and reports no turnover, so the acquisition carries no current revenue contribution
• · Transaction follows an earlier corporate announcement dated September 16, 2026
• · Novuscom was incorporated in India on November 3, 2025 under the Companies Act, 2013
• · Transaction is disclosed as not requiring any governmental or regulatory approval
• · Post-transaction, Novuscom becomes a subsidiary of GEM Enviro Management Limited

19-10-2026

Artemis ADR Marketplace Limited (formerly Jetmall Spices and Masala Limited) disclosed under Regulation 30 that it executed a Software Development and Implementation Services Agreement with Jupitice Justice Technologies Private Limited on April 01, 2026, valued at INR 24.60 Cr. The developer will manage end-to-end delivery of an ADR marketplace platform, with a reference programme running from April 1, 2026 to September 30, 2027. The counterparty is related to the promoter group, as it is a shareholder in the same company, and the transaction would fall within related party transactions, which the company states was done at arm's length.

• · Counterparty Jupitice Justice Technologies Private Limited is a shareholder in the same company, making it a related party; the company states the transaction is at arm's length
• · Agreement is contractor-managed with no deferred functionality
• · Company holds Nil shareholding in the counterparty entity

19-10-2026

Infosys Limited announced via press release dated October 19, 2026 that it will report its second quarter results for the period ended September 30, 2026 on October 23, 2026 at approximately 3:45 p.m. IST. The company also scheduled a press conference at 4:30 p.m. IST and a 60-minute earnings call at 6:00 p.m. IST on the same day, with live webcasts and archived replays available on its Investor Relations website. This is a scheduling announcement and contains no reported financial results.

• · Q2 results (quarter ended September 30, 2026) to be released around 3:45 p.m. IST on October 23, 2026 over wire services
• · Press conference streamed live at 4:30 p.m. IST on October 23, 2026, with archive available after 6:30 p.m. IST
• · Earnings call open to investors and analysts in all regions; archive available after 8:00 p.m. IST, with replay accessible through October 30, 2026
• · Investor questions during the call may be submitted to [email protected]
• · Dial-in numbers provided for India, US, Singapore, Hong Kong, Japan, UK, Germany, Canada, and France; early DiamondPass™ registration encouraged due to limited call capacity

19-10-2026

Microse India Limited has disclosed that Chief Financial Officer Mr. Amit Mishra (also described as Group CFO and Key Managerial Personnel) has resigned due to personal reasons, effective 1 November 2026, and has confirmed no other material reason for leaving. The resignation was filed under Regulation 30 of the SEBI Listing Regulations and the letter of resignation is enclosed.

• · Resignation effective date: 1 November 2026, at which point Mr. Mishra ceases to be CFO and KMP
• · Annexure II resignation letter is dated 19 October 2026 but refers to effective date as '1st November, 2025', an apparent typographical inconsistency with the 2026 effective date stated in the notice
• · Filing references SEBI Master Circular dated 30 January 2026 (No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026)
• · Notice is also uploaded to the company website; scrip code 523343 on BSE

19-10-2026

Piramal Finance Limited's Board approved the appointment of Mr. Dinesh Kumar Khara, former Chairman of the State Bank of India, as an Additional Director designated as Independent Director, effective 19 October 2026 for a five-year term, subject to shareholder approval. The accompanying press release highlights Mr. Khara's tenure at SBI (October 2020 to August 2024), during which SBI's market capitalisation rose from approximately US$20 billion to US$90 billion and net NPA ratio declined from 1.50% in FY21 to 0.57% in FY24. The filing contains no period-over-period financial results for Piramal Finance itself.

• · Appointment is subject to shareholder approval; the Board meeting ran from 2:00 p.m. to 3:25 p.m. on 19 October 2026
• · None of the Directors are inter-se related to Mr. Khara, and he is not debarred from holding office under any SEBI Order or other authority
• · Mr. Khara joined SBI as a Probationary Officer in 1984 and held roles across corporate and international banking, treasury, risk, technology and compliance
• · Mr. Khara received the Business Today Best Banks Lifetime Achievement Award 2025, Financial Express Best Banks Lifetime Achievement Award 2024, and CNN-News18 Indian of the Year 2023 (Business), among other honours
• · Mr. Khara currently serves as an Operating Advisor to the Abu Dhabi Investment Authority
• · Piramal Finance is rated 'AA+' (Stable) by CRISIL, ICRA and CARE, 'BB' by S&P Global, and 'Ba2' (Positive) by Moody's

19-10-2026

Hindustan Zinc Limited filed its Investor Presentation for Q2 and H1 FY27 (quarter and half year ended September 30, 2026), following its financial results declaration. The company reported record quarterly and half-year production, with Q2 revenue from operations of ₹ 15,093 crore (up 77% YoY), EBITDA of ₹ 9,285 crore (up 108% YoY) and net profit of ₹ 6,412 crore (up 142% YoY); H1 revenue from operations was ₹ 28,840 crore (up 77% YoY) and H1 net profit ₹ 11,881 crore (up 143% YoY). Zinc cost of production improved to $703/MT in Q2 (better 29% YoY), though the presentation does not explicitly flag any declining segment.

• · Record Q2 mined metal production of 271 KT and record H1 mined metal production of 539 KT
• · Zinc cost of production of $703/MT in Q2 FY27 and $776/MT in H1 FY27, driven by better mined grades, higher metal production and by-product realisations
• · Silver contributed c.45% to overall profitability
• · Renewable energy at 27% of overall power consumption; HZAPL now sources 100% power from renewable sources
• · Ranked 1st in Metals & Mining sector at S&P Global CSA 2025 for the third consecutive year; first Indian company to join ICMM
• · Consistently rated AAA by CRISIL Ratings Limited
• · Critical mineral block progress: Tungsten exploration started Q4FY26; Potash and REE composite licenses granted; REE & Yttrium LOI received for Gundlupet
• · Industry outlook: structural zinc supply deficit expected post-2030; silver market heading for sixth straight year of deficit in 2026
• · Safety and sustainability: TRIFR at 1.3 in FY26 range trend; zero fatalities reported in FY26 and 1HFY27 per the ESG metrics